Skip to content

Clinical trials

Phase 3 Dermatitis, Atopic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 3 Country / region: China Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20186
20192
20201
20211
20225
20239
202418
20257
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting10
Active, not recruiting7
Unknown status5
Not yet recruiting4
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer7
Sanofi6
Keymed Biosciences Co.Ltd5
AbbVie4
Amgen4
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.4
Akeso2
Otsuka Beijing Research Institute2
Shanghai Mabgeek Biotech.Co.Ltd2
Suzhou Zelgen Biopharmaceuticals Co.,Ltd2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic56
Eczema7
Dermatitis2
Genetic Diseases, Inborn1
Hypersensitivity1
Hypersensitivity, Immediate1
Immune System Diseases1
Skin Diseases1
Skin Diseases, Eczematous1
Skin Diseases, Genetic1

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.